DANIEL J. HICKLIN - 03 Jan 2023 Form 4 Insider Report for Werewolf Therapeutics, Inc. (HOWL)

Role: President and Chief Executive Officer Exhibit Index: 24.1 Power of Attorney, Director
Signature: /s/ Jonathan Owen, Attorney-in-fact
Issuer symbol: HOWL
Transactions as of: 03 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 09 Jan 2023, 20:38:53 UTC
Previous filing: 18 Jan 2022
Next filing: 04 Jan 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HOWL	Stock Option (right to buy)	Award	$0	+295,500		$0.000000	295,500	03 Jan 2023	Common Stock	295,500	$2.05	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option was granted on January 3, 2023 with a Vesting Commencement Date of January 1, 2023. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2027.

Remarks:

President and Chief Executive Officer Exhibit Index: 24.1 Power of Attorney